<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35585354</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>21</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">2366-0058</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Abdominal radiology (New York)</Title>
          <ISOAbbreviation>Abdom Radiol (NY)</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Secondary sclerosing cholangitis: mimics of primary sclerosing cholangitis.</ArticleTitle>
        <Pagination>
          <StartPage>1</StartPage>
          <EndPage>15</EndPage>
          <MedlinePgn>1-15</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00261-022-03551-z</ELocationID>
        <Abstract>
          <AbstractText>Sclerosing cholangitis is a chronic cholestatic disease characterized by stricturing, beading, and obliterative fibrosis of the bile ducts. Sclerosing cholangitis is considered primary (PSC) if no underlying etiology is identified or secondary (SSC) if related to another identifiable cause. In this article, we will review the clinical features, pathogenesis, diagnosis, and imaging findings of PSC and SSC, with an emphasis on features that may aid in the distinction of these entities. We will also discuss various etiologies of SSC including recurrent pyogenic cholangitis, other infectious etiologies, ischemic damage, toxic insults, and immunologic, congenital, and miscellaneous causes, highlighting the unique imaging findings and clinical context of each diagnosis.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ludwig</LastName>
            <ForeName>Daniel R</ForeName>
            <Initials>DR</Initials>
            <Identifier Source="ORCID">0000-0002-8131-3003</Identifier>
            <AffiliationInfo>
              <Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Blvd, Campus Box 8131, Saint Louis, MO, 63110, USA. ludwigd@wustl.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Anderson</LastName>
            <ForeName>Mark A</ForeName>
            <Initials>MA</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Itani</LastName>
            <ForeName>Malak</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S. Kingshighway Blvd, Campus Box 8131, Saint Louis, MO, 63110, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Sharbidre</LastName>
            <ForeName>Kedar G</ForeName>
            <Initials>KG</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, The University of Alabama at Birmingham, Birmingham, AL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lalwani</LastName>
            <ForeName>Neeraj</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Virginia Commonwealth University, Richmond, VA, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Paspulati</LastName>
            <ForeName>Raj M</ForeName>
            <Initials>RM</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Radiology, Case Western Reserve University, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Abdom Radiol (NY)</MedlineTA>
        <NlmUniqueID>101674571</NlmUniqueID>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AIDS cholangiopathy</Keyword>
        <Keyword MajorTopicYN="N">IgG4-related sclerosing cholangitis</Keyword>
        <Keyword MajorTopicYN="N">Ischemic cholangiopathy</Keyword>
        <Keyword MajorTopicYN="N">Recurrent pyogenic cholangitis</Keyword>
        <Keyword MajorTopicYN="N">Secondary sclerosing cholangitis</Keyword>
        <Keyword MajorTopicYN="N">Toxic cholangiopathy</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>25</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>18</Day>
          <Hour>23</Hour>
          <Minute>32</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35585354</ArticleId>
        <ArticleId IdType="pmc">PMC9116710</ArticleId>
        <ArticleId IdType="doi">10.1007/s00261-022-03551-z</ArticleId>
        <ArticleId IdType="pii">10.1007/s00261-022-03551-z</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Khoshpouri P, Habibabadi RR, Hazhirkarzar B, et al (2019) Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up. Radiogr Rev Publ Radiol Soc N Am Inc 39:1938–1964. 10.1148/rg.2019180213</Citation>
        </Reference>
        <Reference>
          <Citation>Lindor KD, Kowdley KV, Harrison ME, American College of Gastroenterology (2015) ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol 110:646–659; quiz 660. 10.1038/ajg.2015.112</Citation>
        </Reference>
        <Reference>
          <Citation>Dyson JK, Beuers U, Jones DEJ, et al.  Primary sclerosing cholangitis. Lancet Lond Engl. 2018;391:2547–2559. doi: 10.1016/S0140-6736(18)30300-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(18)30300-3</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karlsen TH, Folseraas T, Thorburn D, Vesterhus M. Primary sclerosing cholangitis - a comprehensive review. J Hepatol. 2017;67:1298–1323. doi: 10.1016/j.jhep.2017.07.022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2017.07.022</ArticleId>
            <ArticleId IdType="pubmed">28802875</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Singh S, Talwalkar JA. Primary Sclerosing Cholangitis – Diagnosis, Prognosis and Management. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2013;11:898–907. doi: 10.1016/j.cgh.2013.02.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cgh.2013.02.016</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiesner RH. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease. Best Pract Res Clin Gastroenterol. 2001;15:667–680. doi: 10.1053/bega.2001.0212.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/bega.2001.0212</ArticleId>
            <ArticleId IdType="pubmed">11492975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meagher S, Yusoff I, Kennedy W, et al.  The roles of magnetic resonance and endoscopic retrograde cholangiopancreatography (MRCP and ERCP) in the diagnosis of patients with suspected sclerosing cholangitis: a cost-effectiveness analysis. Endoscopy. 2007;39:222–228. doi: 10.1055/s-2007-966253.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-2007-966253</ArticleId>
            <ArticleId IdType="pubmed">17385107</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Talwalkar JA, Angulo P, Johnson CD, et al.  Cost-minimization analysis of MRC versus ERCP for the diagnosis of primary sclerosing cholangitis. Hepatol Baltim Md. 2004;40:39–45. doi: 10.1002/hep.20287.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.20287</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Björnsson E, Lindqvist-Ottosson J, Asztely M, Olsson R. Dominant strictures in patients with primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:502–508. doi: 10.1111/j.1572-0241.2004.04106.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1572-0241.2004.04106.x</ArticleId>
            <ArticleId IdType="pubmed">15056092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boonstra K, Weersma RK, van Erpecum KJ, et al.  Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis. Hepatol Baltim Md. 2013;58:2045–2055. doi: 10.1002/hep.26565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.26565</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vitellas KM, Keogan MT, Freed KS, et al (2000) Radiologic manifestations of sclerosing cholangitis with emphasis on MR cholangiopancreatography. Radiogr Rev Publ Radiol Soc N Am Inc 20:959–975; quiz 1108–1109, 1112. 10.1148/radiographics.20.4.g00jl04959</Citation>
        </Reference>
        <Reference>
          <Citation>Katabathina VS, Dasyam AK, Dasyam N, Hosseinzadeh K (2014) Adult bile duct strictures: role of MR imaging and MR cholangiopancreatography in characterization. Radiogr Rev Publ Radiol Soc N Am Inc 34:565–586. 10.1148/rg.343125211</Citation>
        </Reference>
        <Reference>
          <Citation>Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6:287–295. doi: 10.1038/nrgastro.2009.46.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrgastro.2009.46</ArticleId>
            <ArticleId IdType="pubmed">19404269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gossard AA, Angulo P, Lindor KD. Secondary Sclerosing Cholangitis: A Comparison to Primary Sclerosing Cholangitis. Off J Am Coll Gastroenterol ACG. 2005;100:1330–1333. doi: 10.1111/j.1572-0241.2005.41526.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1572-0241.2005.41526.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brooling J, Leal R. Secondary Sclerosing Cholangitis: a Review of Recent Literature. Curr Gastroenterol Rep. 2017;19:44. doi: 10.1007/s11894-017-0583-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11894-017-0583-8</ArticleId>
            <ArticleId IdType="pubmed">28752474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nishino T, Toki F, Oyama H, et al.  Biliary tract involvement in autoimmune pancreatitis. Pancreas. 2005;30:76–82.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">15632703</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirstein MM, Book T, Manns MP, et al.  Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis. United Eur Gastroenterol J. 2020;8:716–724. doi: 10.1177/2050640620924274.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2050640620924274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voigtländer T, Jaeckel E, Lehner F, et al.  Liver transplantation for critically Ill patients with secondary sclerosing cholangitis: Outcome and complications. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2015;21:1295–1299. doi: 10.1002/lt.24192.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/lt.24192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Catalano OA, Sahani DV, Forcione DG, et al (2009) Biliary infections: spectrum of imaging findings and management. Radiogr Rev Publ Radiol Soc N Am Inc 29:2059–2080. 10.1148/rg.297095051</Citation>
        </Reference>
        <Reference>
          <Citation>Al-Sukhni W, Gallinger S, Pratzer A, et al.  Recurrent Pyogenic Cholangitis with Hepatolithiasis—The Role of Surgical Therapy in North America. J Gastrointest Surg. 2008;12:496–503. doi: 10.1007/s11605-007-0398-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11605-007-0398-2</ArticleId>
            <ArticleId IdType="pubmed">17999121</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tsui WM, Chan Y, Wong C, et al.  Hepatolithiasis and the Syndrome of Recurrent Pyogenic Cholangitis: Clinical, Radiologic, and Pathologic Features. Semin Liver Dis. 2011;31:033–048. doi: 10.1055/s-0031-1272833.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1055/s-0031-1272833</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Heffernan EJ, Geoghegan T, Munk PL, et al.  Recurrent pyogenic cholangitis: from imaging to intervention. AJR Am J Roentgenol. 2009;192:W28–35. doi: 10.2214/AJR.08.1104.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.08.1104</ArticleId>
            <ArticleId IdType="pubmed">19098169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leung JW, Yu AS. Hepatolithiasis and biliary parasites. Baillieres Clin Gastroenterol. 1997;11:681–706. doi: 10.1016/s0950-3528(97)90016-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0950-3528(97)90016-6</ArticleId>
            <ArticleId IdType="pubmed">9512805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan FL, Man SW, Leong LL, Fan ST. Evaluation of recurrent pyogenic cholangitis with CT: analysis of 50 patients. Radiology. 1989;170:165–169. doi: 10.1148/radiology.170.1.2909092.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/radiology.170.1.2909092</ArticleId>
            <ArticleId IdType="pubmed">2909092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Menias CO, Surabhi VR, Prasad SR, et al (2008) Mimics of cholangiocarcinoma: spectrum of disease. Radiogr Rev Publ Radiol Soc N Am Inc 28:1115–1129. 10.1148/rg.284075148</Citation>
        </Reference>
        <Reference>
          <Citation>Choi D, Lim JH, Lee KT, et al.  Cholangiocarcinoma and Clonorchis sinensis infection: a case-control study in Korea. J Hepatol. 2006;44:1066–1073. doi: 10.1016/j.jhep.2005.11.040.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2005.11.040</ArticleId>
            <ArticleId IdType="pubmed">16480786</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinç H, Arslan MK, Sayil null, Gümele HR, Biliary ascariasis associated with cholangiocarcinoma: ultrasonographic and percutaneous transhepatic cholangiographic findings. Eur Radiol. 1998;8:788–790. doi: 10.1007/s003300050473.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s003300050473</ArticleId>
            <ArticleId IdType="pubmed">9601966</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chow L, t. c., Ahuja A t., Kwong K h,, et al.  Mucinous cholangiocarcinoma: an unusual complication of hepatolithiasis and recurrent pyogenic cholangitis. Histopathology. 1997;30:491–494. doi: 10.1046/j.1365-2559.1997.00542.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2559.1997.00542.x</ArticleId>
            <ArticleId IdType="pubmed">9181374</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Metwally O, Man K. The role of endoscopy in the management of recurrent pyogenic cholangitis: a review. J Community Hosp Intern Med Perspect. 2015 doi: 10.3402/jchimp.v5.27858.10.3402/jchimp.v5.27858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3402/jchimp.v5.27858.10.3402/jchimp.v5.27858</ArticleId>
            <ArticleId IdType="pmc">PMC4558289</ArticleId>
            <ArticleId IdType="pubmed">26333855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mahajani RV, Uzer MF. Cholangiopathy in HIV-infected patients. Clin Liver Dis. 1999;3:669–684. doi: 10.1016/S1089-3261(05)70090-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1089-3261(05)70090-8</ArticleId>
            <ArticleId IdType="pubmed">11291244</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Abdalian R, Heathcote EJ. Sclerosing cholangitis: A focus on secondary causes. Hepatology. 2006;44:1063–1074. doi: 10.1002/hep.21405.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.21405</ArticleId>
            <ArticleId IdType="pubmed">17058222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naseer M, Dailey FE, Juboori AA, et al.  Epidemiology, determinants, and management of AIDS cholangiopathy: A review. World J Gastroenterol. 2018;24:767–774. doi: 10.3748/wjg.v24.i7.767.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v24.i7.767</ArticleId>
            <ArticleId IdType="pmc">PMC5807936</ArticleId>
            <ArticleId IdType="pubmed">29467548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Faruqui S, Okoli FC, Olsen SK, et al.  Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications. Am J Gastroenterol. 2021;116:1414–1425. doi: 10.14309/ajg.0000000000001264.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14309/ajg.0000000000001264</ArticleId>
            <ArticleId IdType="pubmed">33993134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Edwards K, Allison M, Ghuman S. Secondary sclerosing cholangitis in critically ill patients: a rare disease precipitated by severe SARS-CoV-2 infection. BMJ Case Rep. 2020;13:e237984. doi: 10.1136/bcr-2020-237984.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bcr-2020-237984</ArticleId>
            <ArticleId IdType="pmc">PMC7654135</ArticleId>
            <ArticleId IdType="pubmed">33168538</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Klindt C, Jensen B-E, Brandenburger T, et al.  Secondary sclerosing cholangitis as a complication of severe COVID-19: A case report and review of the literature. Clin Case Rep. 2021;9:e04068. doi: 10.1002/ccr3.4068.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ccr3.4068</ArticleId>
            <ArticleId IdType="pmc">PMC8142800</ArticleId>
            <ArticleId IdType="pubmed">34084492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Durazo FA, Nicholas AA, Mahaffey JJ, et al.  Post-Covid-19 Cholangiopathy-A New Indication for Liver Transplantation: A Case Report. Transplant Proc. 2021;53:1132–1137. doi: 10.1016/j.transproceed.2021.03.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.transproceed.2021.03.007</ArticleId>
            <ArticleId IdType="pmc">PMC7953456</ArticleId>
            <ArticleId IdType="pubmed">33846012</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vellar ID. The blood supply of the biliary ductal system and its relevance to vasculobiliary injuries following cholecystectomy. Aust N Z J Surg. 1999;69:816–820. doi: 10.1046/j.1440-1622.1999.01702.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1440-1622.1999.01702.x</ArticleId>
            <ArticleId IdType="pubmed">10553973</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wozney P, Zajko AB, Bron KM, et al.  Vascular complications after liver transplantation: a 5-year experience. AJR Am J Roentgenol. 1986;147:657–663. doi: 10.2214/ajr.147.4.657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.147.4.657</ArticleId>
            <ArticleId IdType="pmc">PMC3095891</ArticleId>
            <ArticleId IdType="pubmed">3529892</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sugi MD, Albadawi H, Knuttinen G, et al.  Transplant artery thrombosis and outcomes. Cardiovasc Diagn Ther. 2017;7:S219–S227. doi: 10.21037/cdt.2017.10.13.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.21037/cdt.2017.10.13</ArticleId>
            <ArticleId IdType="pmc">PMC5778523</ArticleId>
            <ArticleId IdType="pubmed">29399525</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Buis CI, Hoekstra H, Verdonk RC, Porte RJ. Causes and consequences of ischemic-type biliary lesions after liver transplantation. J Hepatobiliary Pancreat Surg. 2006;13:517–524. doi: 10.1007/s00534-005-1080-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00534-005-1080-2</ArticleId>
            <ArticleId IdType="pubmed">17139425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Giesbrandt KJ, Bulatao IG, Keaveny AP, et al.  Radiologic Characterization of Ischemic Cholangiopathy in Donation-After-Cardiac-Death Liver Transplants and Correlation With Clinical Outcomes. AJR Am J Roentgenol. 2015;205:976–984. doi: 10.2214/AJR.14.13383.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.14.13383</ArticleId>
            <ArticleId IdType="pmc">PMC4841999</ArticleId>
            <ArticleId IdType="pubmed">26496544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mourad MM, Liossis C, Gunson BK, et al.  Etiology and management of hepatic artery thrombosis after adult liver transplantation. Liver Transpl. 2014;20:713–723. doi: 10.1002/lt.23874.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/lt.23874</ArticleId>
            <ArticleId IdType="pubmed">24652787</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leonhardt S, Veltzke-Schlieker W, Adler A, et al.  Secondary Sclerosing Cholangitis in Critically Ill Patients: Clinical Presentation, Cholangiographic Features, Natural History, and Outcome: A Series of 16 Cases. Medicine (Baltimore) 2015;94:e2188. doi: 10.1097/MD.0000000000002188.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000002188</ArticleId>
            <ArticleId IdType="pmc">PMC5008492</ArticleId>
            <ArticleId IdType="pubmed">26656347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alabdulghani F, Healy GM, Cantwell CP. Radiological findings in ischaemic cholangiopathy. Clin Radiol. 2020;75:161–168. doi: 10.1016/j.crad.2019.10.017.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.crad.2019.10.017</ArticleId>
            <ArticleId IdType="pubmed">31791625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Strnad BS, Ludwig DR, Gilcrease-Garcia B, et al.  Contemporary Imaging of the Surgically Placed Hepatic Arterial Infusion Chemotherapy Pump. AJR Am J Roentgenol. 2021;217:633–643. doi: 10.2214/AJR.20.24437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/AJR.20.24437</ArticleId>
            <ArticleId IdType="pubmed">33025806</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barnett KT, Malafa MP. Complications of hepatic artery infusion. Int J Gastrointest Cancer. 2001;30:147–160. doi: 10.1385/IJGC:30:3:147.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1385/IJGC:30:3:147</ArticleId>
            <ArticleId IdType="pubmed">12540027</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Visentin M, Lenggenhager D, Gai Z, Kullak-Ublick GA. Drug-induced bile duct injury. Biochim Biophys Acta Mol Basis Dis. 2018;1864:1498–1506. doi: 10.1016/j.bbadis.2017.08.033.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbadis.2017.08.033</ArticleId>
            <ArticleId IdType="pubmed">28882625</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kusakabe A, Ohkawa K, Fukutake N, et al.  Chemotherapy-Induced Sclerosing Cholangitis Caused by Systemic Chemotherapy. ACG Case Rep J. 2019;6:e00136. doi: 10.14309/crj.0000000000000136.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14309/crj.0000000000000136</ArticleId>
            <ArticleId IdType="pmc">PMC6722363</ArticleId>
            <ArticleId IdType="pubmed">31620533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Castellano G, Moreno-Sanchez D, Gutierrez J, et al.  Caustic sclerosing cholangitis. Report of four cases and a cumulative review of the literature. Hepatogastroenterology. 1994;41:458–470.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7851856</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sappati Biyyani RS, Chak A. Contrast-Induced Auto-Immune Phenomenon Resulting in Granulomatous Cholangiopathy: 515. Off J Am Coll Gastroenterol ACG. 2013;108:S152. doi: 10.14309/00000434-201310001-00515.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14309/00000434-201310001-00515</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gudnason HO, Björnsson HK, Gardarsdottir M, et al.  Secondary sclerosing cholangitis in patients with drug-induced liver injury. Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver. 2015;47:502–507. doi: 10.1016/j.dld.2015.03.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.dld.2015.03.002</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Culver EL, Barnes E. IgG4-related sclerosing cholangitis. Clin Liver Dis. 2017;10:9–16. doi: 10.1002/cld.642.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cld.642</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Deshpande V, Zen Y, Chan JK, et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol Off J U S Can Acad Pathol Inc 25:1181–1192. 10.1038/modpathol.2012.72</Citation>
        </Reference>
        <Reference>
          <Citation>Ghazale A, Chari ST, Zhang L, et al.  Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology. 2008;134:706–715. doi: 10.1053/j.gastro.2007.12.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.gastro.2007.12.009</ArticleId>
            <ArticleId IdType="pubmed">18222442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chari ST. Diagnosis of autoimmune pancreatitis using its five cardinal features: introducing the Mayo Clinic’s HISORt criteria. J Gastroenterol. 2007;42:39–41. doi: 10.1007/s00535-007-2046-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00535-007-2046-8</ArticleId>
            <ArticleId IdType="pubmed">17520222</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakazawa T, Kamisawa T, Okazaki K, et al.  Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020: (Revision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012) J Hepato-Biliary-Pancreat Sci. 2021;28:235–242. doi: 10.1002/jhbp.913.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jhbp.913</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakazawa T, Ohara H, Sano H, et al.  Schematic classification of sclerosing cholangitis with autoimmune pancreatitis by cholangiography. Pancreas. 2006;32:229. doi: 10.1097/01.mpa.0000202941.85955.07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.mpa.0000202941.85955.07</ArticleId>
            <ArticleId IdType="pubmed">16552350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chapman R, Fevery J, Kalloo A, et al.  Diagnosis and management of primary sclerosing cholangitis. Hepatol Baltim Md. 2010;51:660–678. doi: 10.1002/hep.23294.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.23294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee HE, Zhang L. Immunoglobulin G4-related hepatobiliary disease. Semin Diagn Pathol. 2019;36:423–433. doi: 10.1053/j.semdp.2019.07.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1053/j.semdp.2019.07.007</ArticleId>
            <ArticleId IdType="pubmed">31358425</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nakanuma Y, Zen Y. Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: The latest addition to the sclerosing cholangitis family. Hepatol Res Off J Jpn Soc Hepatol. 2007;37(Suppl 3):S478–486. doi: 10.1111/j.1872-034X.2007.00243.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1872-034X.2007.00243.x</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seo N, Kim SY, Lee SS, et al.  Sclerosing Cholangitis: Clinicopathologic Features, Imaging Spectrum, and Systemic Approach to Differential Diagnosis. Korean J Radiol. 2016;17:25–38. doi: 10.3348/kjr.2016.17.1.25.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3348/kjr.2016.17.1.25</ArticleId>
            <ArticleId IdType="pmc">PMC4720808</ArticleId>
            <ArticleId IdType="pubmed">26798213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Huggett MT, Culver EL, Kumar M, et al.  Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure, malignancy, and mortality in a prospective UK cohort. Am J Gastroenterol. 2014;109:1675–1683. doi: 10.1038/ajg.2014.223.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ajg.2014.223</ArticleId>
            <ArticleId IdType="pmc">PMC4552254</ArticleId>
            <ArticleId IdType="pubmed">25155229</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hirano K, Tada M, Sasahira N, et al.  Incidence of malignancies in patients with IgG4-related disease. Intern Med Tokyo Jpn. 2014;53:171–176. doi: 10.2169/internalmedicine.53.1342.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.53.1342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tenner S, Roston A, Lichtenstein D, et al.  Eosinophilic cholangiopathy. Gastrointest Endosc. 1997;45:307–309. doi: 10.1016/S0016-5107(97)70277-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0016-5107(97)70277-3</ArticleId>
            <ArticleId IdType="pubmed">9087841</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nashed C, Sakpal SV, Shusharina V, Chamberlain RS. Eosinophilic Cholangitis and Cholangiopathy: A Sheep in Wolves Clothing. HPB Surg. 2010;2010:906496. doi: 10.1155/2010/906496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2010/906496</ArticleId>
            <ArticleId IdType="pmc">PMC2976516</ArticleId>
            <ArticleId IdType="pubmed">21076681</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fragulidis GP, Vezakis AI, Kontis EA, et al.  Eosinophilic Cholangitis—A Challenging Diagnosis of Benign Biliary Stricture. Medicine (Baltimore) 2016;95:e2394. doi: 10.1097/MD.0000000000002394.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MD.0000000000002394</ArticleId>
            <ArticleId IdType="pmc">PMC4706259</ArticleId>
            <ArticleId IdType="pubmed">26735539</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Matsumoto N, Yokoyama K, Nakai K, et al.  A case of eosinophilic cholangitis: Imaging findings of contrast-enhanced ultrasonography, cholangioscopy, and intraductal ultrasonography. World J Gastroenterol WJG. 2007;13:1995–1997. doi: 10.3748/wjg.v13.i13.1995.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v13.i13.1995</ArticleId>
            <ArticleId IdType="pmc">PMC4146980</ArticleId>
            <ArticleId IdType="pubmed">17461504</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Björnsson ES, Andrade RJ. Long-term sequelae of drug-induced liver injury. J Hepatol. 2022;76:435–445. doi: 10.1016/j.jhep.2021.10.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jhep.2021.10.011</ArticleId>
            <ArticleId IdType="pubmed">34688732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pi B, Wang J, Tong Y, et al.  Immune-related cholangitis induced by immune checkpoint inhibitors: a systematic review of clinical features and management. Eur J Gastroenterol Hepatol. 2021;33:e858. doi: 10.1097/MEG.0000000000002280.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/MEG.0000000000002280</ArticleId>
            <ArticleId IdType="pmc">PMC8734631</ArticleId>
            <ArticleId IdType="pubmed">34482313</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Onoyama T, Takeda Y, Yamashita T, et al.  Programmed cell death-1 inhibitor-related sclerosing cholangitis: A systematic review. World J Gastroenterol. 2020;26:353–365. doi: 10.3748/wjg.v26.i3.353.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v26.i3.353</ArticleId>
            <ArticleId IdType="pmc">PMC6969883</ArticleId>
            <ArticleId IdType="pubmed">31988594</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levy AD, Rohrmann CA, Murakata LA, Lonergan GJ. Caroli’s Disease: Radiologic Spectrum with Pathologic Correlation. Am J Roentgenol. 2002;179:1053–1057. doi: 10.2214/ajr.179.4.1791053.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2214/ajr.179.4.1791053</ArticleId>
            <ArticleId IdType="pubmed">12239064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khalefa AA, Alrasheed M, Saeedan MB. Central dot sign. Abdom Radiol. 2016;41:2289–2290. doi: 10.1007/s00261-016-0836-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-016-0836-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yonem O, Bayraktar Y. Clinical characteristics of Caroli’s disease. World J Gastroenterol WJG. 2007;13:1930–1933. doi: 10.3748/wjg.v13.i13.1930.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v13.i13.1930</ArticleId>
            <ArticleId IdType="pmc">PMC4146968</ArticleId>
            <ArticleId IdType="pubmed">17461492</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Assis DN, Debray D. Gallbladder and bile duct disease in Cystic Fibrosis. J Cyst Fibros. 2017;16:S62–S69. doi: 10.1016/j.jcf.2017.07.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jcf.2017.07.006</ArticleId>
            <ArticleId IdType="pubmed">28986023</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lavelle LP, McEvoy SH, Mhurchu EN, et al.  Cystic Fibrosis below the Diaphragm: Abdominal Findings in Adult Patients. RadioGraphics. 2015 doi: 10.1148/rg.2015140110.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1148/rg.2015140110</ArticleId>
            <ArticleId IdType="pubmed">26466187</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Khuroo MS, Rather AA, Khuroo NS, Khuroo MS. Portal biliopathy. World J Gastroenterol. 2016;22:7973–7982. doi: 10.3748/wjg.v22.i35.7973.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v22.i35.7973</ArticleId>
            <ArticleId IdType="pmc">PMC5028811</ArticleId>
            <ArticleId IdType="pubmed">27672292</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ramesh Babu CS, Sharma M. Biliary tract anatomy and its relationship with venous drainage. J Clin Exp Hepatol. 2014;4:S18–26. doi: 10.1016/j.jceh.2013.05.002.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jceh.2013.05.002</ArticleId>
            <ArticleId IdType="pmc">PMC4244820</ArticleId>
            <ArticleId IdType="pubmed">25755590</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kessler A, Graif M, Konikoff F, et al.  Vascular and Biliary Abnormalities Mimicking Cholangiocarcinoma in Patients With Cavernous Transformation of the Portal Vein. J Ultrasound Med. 2007;26:1089–1095. doi: 10.7863/jum.2007.26.8.1089.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7863/jum.2007.26.8.1089</ArticleId>
            <ArticleId IdType="pubmed">17646372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Puri P. Pathogenesis of Portal Cavernoma Cholangiopathy: Is it Compression by Collaterals or Ischemic Injury to Bile Ducts During Portal Vein Thrombosis? J Clin Exp Hepatol. 2014;4:S27–33. doi: 10.1016/j.jceh.2013.05.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jceh.2013.05.015</ArticleId>
            <ArticleId IdType="pmc">PMC4244823</ArticleId>
            <ArticleId IdType="pubmed">25755592</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dhiman RK, Behera A, Chawla YK, et al.  Portal hypertensive biliopathy. Gut. 2007;56:1001–1008. doi: 10.1136/gut.2006.103606.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.2006.103606</ArticleId>
            <ArticleId IdType="pmc">PMC1994341</ArticleId>
            <ArticleId IdType="pubmed">17170017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Llop E, de Juan C, Seijo S, et al.  Portal cholangiopathy: radiological classification and natural history. Gut. 2011;60:853–860. doi: 10.1136/gut.2010.230201.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/gut.2010.230201</ArticleId>
            <ArticleId IdType="pubmed">21270119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hui CL, Loo ZY. Vascular disorders of the gallbladder and bile ducts: Imaging findings. J Hepato-Biliary-Pancreat Sci. 2021;28:825–836. doi: 10.1002/jhbp.930.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jhbp.930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chattopadhyay S, Nundy S. Portal biliopathy. World J Gastroenterol WJG. 2012;18:6177–6182. doi: 10.3748/wjg.v18.i43.6177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3748/wjg.v18.i43.6177</ArticleId>
            <ArticleId IdType="pmc">PMC3501764</ArticleId>
            <ArticleId IdType="pubmed">23180936</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kennedy PTF, Zakaria N, Modawi SB, et al.  Natural history of hepatic sarcoidosis and its response to treatment. Eur J Gastroenterol Hepatol. 2006;18:721–726. doi: 10.1097/01.meg.0000223911.85739.38.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/01.meg.0000223911.85739.38</ArticleId>
            <ArticleId IdType="pubmed">16772828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ishak KG. Sarcoidosis of the Liver and Bile Ducts. Mayo Clin Proc. 1998;73:467–472. doi: 10.1016/S0025-6196(11)63733-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0025-6196(11)63733-6</ArticleId>
            <ArticleId IdType="pubmed">9581591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tadros M, Forouhar F, Wu GY. Hepatic Sarcoidosis. J Clin Transl Hepatol. 2013;1:87–93. doi: 10.14218/JCTH.2013.00016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14218/JCTH.2013.00016</ArticleId>
            <ArticleId IdType="pmc">PMC4521279</ArticleId>
            <ArticleId IdType="pubmed">26357609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Karaosmanoğlu AD, Onur MR, Saini S, et al.  Imaging of hepatobiliary involvement in sarcoidosis. Abdom Imaging. 2015;40:3330–3337. doi: 10.1007/s00261-015-0533-6.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00261-015-0533-6</ArticleId>
            <ArticleId IdType="pubmed">26318751</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ganeshan D, Menias CO, Lubner MG, et al (2018) Sarcoidosis from Head to Toe: What the Radiologist Needs to Know. Radiogr Rev Publ Radiol Soc N Am Inc 38:1180–1200. 10.1148/rg.2018170157</Citation>
        </Reference>
        <Reference>
          <Citation>Hirano K, Ikemura M, Mizuno S, et al.  Two cases with hepatic amyloidosis suspected of having primary sclerosing cholangitis. Hepatol Res. 2013;43:911–916. doi: 10.1111/hepr.12034.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/hepr.12034</ArticleId>
            <ArticleId IdType="pubmed">23675805</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clough J, Shah R. Primary Amyloidosis Presenting as Common Bile Duct Obstruction With Cholangitis. ACG Case Rep J. 2015;2:107–109. doi: 10.14309/crj.2015.20.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.14309/crj.2015.20</ArticleId>
            <ArticleId IdType="pmc">PMC4435380</ArticleId>
            <ArticleId IdType="pubmed">26157929</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Terada T, Nakanuma Y. Intrahepatic cholangiographic appearance simulating primary sclerosing cholangitis in several hepatobiliary diseases: a postmortem cholangiographic and histopathological study in 154 livers at autopsy. Hepatol Baltim Md. 1995;22:75–81. doi: 10.1002/hep.1840220112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.1840220112</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
